Stock Screener App

Frei -

Installieren

4.1399

0.73% 0.0299

after-market

Handel nachbörslich: 4.13 -0.0099 -0.24%

Purple Biotech Ltd Adr (PPBT)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Purple Biotech Ltd Adr Aktie (PPBT) Neueste Nachrichten

Purple Biotech Ltd (PPBT) Stock Price, Trades & News - gurufocus.com

Purple Biotech Ltd (FRA:1YI0) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Purple Biotech Ltd (FRA:1YI0) Valuation - gurufocus.com

PPBT Stock Price, Quote & Chart | PURPLE BIOTECH LTD-ADR (NASDAQ:PPBT) - ChartMill

Purple Biotech Ltd Stock Baskets - gurufocus.com

Purple Biotech Ltd (STU:1YI0) Competitors 2026 - gurufocus.com

Purple Biotech Ltd (STU:1YI0) Valuation - GuruFocus

Purple Biotech Ltd (STU:1YI0) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Purple Biotech Ltd (STU:1YI0) Stock Price, Trades & News - gurufocus.com

Purple Biotech Ltd (STU:1YI0) Dividend - gurufocus.com

Who's Buying or Selling Purple Biotech Ltd (STU:1YI0) Stock Today? - GuruFocus

Purple Biotech Ltd (STU:1YI0) Stock News, Headlines & Updates - GuruFocus

Purple Biotech Ltd Stock Operating Data - GuruFocus

Purple Biotech Ltd Stock Intrinsic Values - GuruFocus

Purple Biotech Ltd Stock Warning Signs - GuruFocus

Purple Biotech Ltd Stock Historical Valuations | STU:1YI0 - GuruFocus

Purple Biotech (NASDAQ: PPBT) outlines losses, pipeline and funding risks in 2025 20-F - Stock Titan

Form 6K PURPLE BIOTECH LTD. For: 17 March - Investing.com

Diluted earnings per share (diluted EPS) of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Average basic shares outstanding of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

H.C. Wainwright cuts Purple Biotech stock price target to $30 By Investing.com - Investing.com South Africa

H.C. Wainwright cuts Purple Biotech stock price target to $30 - Investing.com

Preferred dividends of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Purple Biotech CEO Gil Efron to step down in August 2026 - Investing.com India

Purple Biotech Announces CEO Transition - ChartMill

Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results - ChartMill

Dilution adjustment of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

After tax other income/expense of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Cash from financing activities of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Cash from operating activities of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Diluted shares outstanding of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Revenue per share of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Debt to equity ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Asset turnover of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Net margin % of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Price to book ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Long term debt to total equity ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Income Statement – FWB:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Statistics – FWB:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Earnings and Revenue – FWB:1YI0 - TradingView

Net debt of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Balance Sheet – FWB:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Financial Statements – FWB:1YI0 - TradingView

Net income of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView

Operating margin % of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Earnings and Revenue – GETTEX:1YI0 - TradingView

Inventory turnover of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Net debt of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

After tax other income/expense of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Financial Statements – GETTEX:1YI0 - TradingView

Total liabilities & shareholders' equities of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Total liabilities of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Operating expenses (excl. COGS) of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Preferred dividends of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Cash Flow – GETTEX:1YI0 - TradingView

Total operating expenses of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Non-operating income (total) of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Non-controlling/minority interest of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Income Statement – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Dividends – GETTEX:1YI0 - TradingView

Purple Biotech Ltd. Sponsored ADR Revenue Breakdown – GETTEX:1YI0 - TradingView

Purple Biotech Ltd Share Price ADR Each Representing 2000 Ord Shares SPON - hl.co.uk

Purple Biotech Ltd. Sponsored ADR Cash Flow – MUN:1YI0 - TradingView

Total liabilities & shareholders' equities of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Total liabilities of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Diluted net income available to common stockholders of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

Net debt of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

PPBT Earnings History & Surprises | EPS & Revenue Results | PURPLE BIOTECH LTD-ADR (NASDAQ:PPBT) - ChartMill

Purple Biotech Ltd. Sponsored ADR Balance Sheet – MUN:1YI0 - TradingView

Equity in earnings of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters